Only about one in six historically marginalized children with uncontrolled asthma in a Rochester, New York-based study saw an asthma specialist in the past year, despite clinical guidance recommending ...

Dec 12 (Reuters) - The European Medicines Agency has recommended the approval of GSK's (GSK.L), opens new tab add-on drug to treat asthma and a chronic inflammatory sinus condition, the company said ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won European regulatory approval for two inflammatory disease indications. The European Medicines Agency's ...

Please provide your email address to receive an email when new articles are posted on . The COVID-adjusted annualized asthma exacerbation rate dropped by 46%. Mean cumulative oral corticosteroid dose ...

Please provide your email address to receive an email when new articles are posted on . The annualized exacerbation rate was 3.18 per patient-year before tezepelumab and 1.97 per patient-year after ...

Scientists found that RSV infection early in life can set the stage for childhood asthma, particularly in kids already genetically prone to allergies. The virus appears to skew the developing immune ...

Like any medication, Dupixent may cause various side effects. It’s especially known to cause side effects relating to the eyes, such as conjunctivitis, blepharitis, and keratitis. These side effects ...

An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. The drug dupilumab (Dupixent) effectively clears up airways ...

Xdemvy (lotilaner ophthalmic solution) is a brand-name prescription eye drop used in adults to treat blepharitis (eyelid inflammation) caused by Demodex mites. As with other drugs, Xdemvy can cause ...